AGER and chronic obstructive pulmonary disease: Additionally, since HMGB1 acting on RAGE and TLR4 represents key pathways for the formation of cigarette-smoke-induced COPD inflammation [162,163], increased pulmonary expression of HMGB1 in COPD is a further potential target for inhaled heparin therapy.